These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 27906153)

  • 1. Addendum: Statins for primary prevention of cardiovascular disease.
    Med Lett Drugs Ther; 2016 Dec; 58(1509):158. PubMed ID: 27906153
    [No Abstract]   [Full Text] [Related]  

  • 2. [Statins in primary prevention of cardiovascular disease].
    Adham S; Miranda S; Doucet J; Lévesque H; Benhamou Y
    Rev Med Interne; 2018 Jan; 39(1):42-49. PubMed ID: 28866432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary prevention for cardiovascular diseases: can statins replace aspirin?
    Abdul Hadi M; Ming LC; Awaisu A
    Med Princ Pract; 2011; 20(6):584. PubMed ID: 21986022
    [No Abstract]   [Full Text] [Related]  

  • 4. Statins and all-cause mortality in high-risk primary prevention of patients with cardiovascular risk factors.
    Brugts JJ; Deckers JW
    Arch Intern Med; 2010 Dec; 170(22):2041; author reply 2043-4. PubMed ID: 21149768
    [No Abstract]   [Full Text] [Related]  

  • 5. Statins for primary prevention of cardiovascular disease.
    Majeed A
    BMJ; 2014 May; 348():g3491. PubMed ID: 24868092
    [No Abstract]   [Full Text] [Related]  

  • 6. Are statins effective in high-risk primary prevention?
    Dentali F; Guasti L
    Arch Intern Med; 2010 Dec; 170(22):2042-3; author reply 2043-4. PubMed ID: 21149769
    [No Abstract]   [Full Text] [Related]  

  • 7. What is the role of statins in the elderly population?
    Stavropoulos K; Imprialos K; Doumas M; Athyros VG
    Expert Rev Clin Pharmacol; 2018 Apr; 11(4):329-331. PubMed ID: 29431524
    [No Abstract]   [Full Text] [Related]  

  • 8. Statins underused for primary prevention in older patients.
    Savill P
    Practitioner; 2012 Sep; 256(1754):5. PubMed ID: 23252128
    [No Abstract]   [Full Text] [Related]  

  • 9. Update on statins and other lipid-lowering drugs.
    Miller CA
    Geriatr Nurs; 2001; 22(5):276-7. PubMed ID: 11606910
    [No Abstract]   [Full Text] [Related]  

  • 10. Statins: have we found the Holy Grail?
    Jeger R; Dieterle T
    Swiss Med Wkly; 2012; 142():w13515. PubMed ID: 22315166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins and all-cause mortality in high-risk primary prevention: a second look at the results.
    Chodick G; Shalev V
    Arch Intern Med; 2010 Dec; 170(22):2041-2; author reply 2043-4. PubMed ID: 21149767
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary prevention cardiovascular disease: better than drugs.
    Pippin JJ
    Arch Intern Med; 2010 Nov; 170(20):1860-1; author reply 1861. PubMed ID: 21059984
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of Heart Outcomes Prevention Evaluation Trial on Statin Eligibility for the Primary Prevention of Cardiovascular Disease: Insights from the National Health and Nutrition Examination Survey.
    Burstein B; Altobelli KK; Williams K; Cannon CP; Pencina MJ; Sniderman AD; Thanassoulis G
    Circulation; 2017 Nov; 136(19):1860-1862. PubMed ID: 29109198
    [No Abstract]   [Full Text] [Related]  

  • 14. Statins for primary prevention in people with a 10% 10-year cardiovascular risk: too much medicine too soon?
    Yerrakalva D; Griffin SJ
    Br J Gen Pract; 2017 Jan; 67(654):40-41. PubMed ID: 28034950
    [No Abstract]   [Full Text] [Related]  

  • 15. Statins in primary prevention: is the enthusiasm justified?
    Chopra AK; Yadav R
    Indian Heart J; 2020; 72(4):221-224. PubMed ID: 32861373
    [No Abstract]   [Full Text] [Related]  

  • 16. Statins for the primary prevention of cardiovascular events in elderly patients: a picture from clinical practice without strong evidence from clinical trials.
    Trifirò G; Alacqua M; Corrao S; Tari M; Arcoraci V
    J Am Geriatr Soc; 2008 Jan; 56(1):175-7. PubMed ID: 18184214
    [No Abstract]   [Full Text] [Related]  

  • 17. Emerging clinical challenges in the use of statins.
    Hennekens CH; Breuer NR; Gelb IJ; Bjorkman DJ; Borer JS; Pfeffer MA
    Am J Med; 2013 Aug; 126(8):663-4. PubMed ID: 23786669
    [No Abstract]   [Full Text] [Related]  

  • 18. Bad medicine: statins.
    Spence D
    BMJ; 2013 May; 346():f3566. PubMed ID: 23729321
    [No Abstract]   [Full Text] [Related]  

  • 19. [Primary prevention of cardiovascular diseases with statins in patients with diabetes].
    Macías Saint-Gerons D; de la Fuente Honrubia C; de Andrés-Trelles F; Catalá-López F
    Med Clin (Barc); 2015 Mar; 144(6):285-7. PubMed ID: 24954712
    [No Abstract]   [Full Text] [Related]  

  • 20. Benefit/risk ratio of statins in primary prevention.
    Reidenberg MM
    Clin Pharmacol Ther; 2008 Mar; 83(3):498-500. PubMed ID: 17538549
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.